Exelixis
EXEL
#1795
Rank
โ‚น1.104 T
Marketcap
โ‚น4,120
Share price
-0.23%
Change (1 day)
31.68%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2025 (TTM): โ‚น82.43 Billion

According to Exelixis's latest financial reports the company's current earnings are โ‚น2.32 Billion. , an increase over its 2024 earnings that were of โ‚น63.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น87.76 B38.08%
2024 โ‚น63.56 B164.69%
2023 โ‚น24.01 B9.89%
2022 โ‚น21.85 B-20.33%
2021 โ‚น27.43 B124.82%
2020 โ‚น12.20 B-67.14%
2019 โ‚น37.12 B-11.94%
2018 โ‚น42.15 B185.09%
2017 โ‚น14.78 B-325.82%
2016 -โ‚น6.55 Billion-58.12%
2015 -โ‚น15.64 Billion-37.61%
2014 -โ‚น25.06 Billion9.75%
2013 -โ‚น22.84 Billion65.96%
2012 -โ‚น13.76 Billion-291.63%
2011 โ‚น7.17 B-195.59%
2010 -โ‚น7.52 Billion-42.17%
2009 -โ‚น12.99 Billion-18.98%
2008 -โ‚น16.04 Billion-6.99%
2007 -โ‚น17.24 Billion46.3%
2006 -โ‚น11.79 Billion33.25%
2005 -โ‚น8.85 Billion-30.92%
2004 -โ‚น12.8 Billion44.29%
2003 -โ‚น8.87 Billion12.86%
2002 -โ‚น7.86 Billion22.79%
2001 -โ‚น6.41 Billion60.14%
2000 -โ‚น4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.128 T 3,464.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น950.41 B 982.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น837.02 B 853.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น717.96 B 718.02%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น2.090 T 2,282.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น869.84 B 891.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น922.79 B 951.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-โ‚น3.04 Billion-103.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น2.71 Billion-103.09%๐Ÿ‡บ๐Ÿ‡ธ USA